|
시장보고서
상품코드
2119468
단기 작용 피임약 시장 규모, 점유율, 성장 분석 : 제품 유형별, 호르몬 유형별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Short Acting Contraceptives Market Size, Share, and Growth Analysis, By Product Type (Oral Contraceptive Pills, Injectable Contraceptives), By Hormone Type, By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 단기 작용 피임약 시장 규모는 2024년에 2,300만 달러로 평가되며, 2025년 2,374만 달러에서 2033년까지 3,054만 달러로 확대될 전망이며, 예측 기간(2026-2033년) 동안 CAGR 3.2%로 성장할 것으로 전망됩니다.
세계 단기 작용 피임약 시장은 처방 절차를 간소화하고 접근성을 확대하는 디지털 헬스 플랫폼의 부상으로 인해 눈부신 성장을 이루고 있습니다. 원격의료를 통해 특히 외진 지역에 거주하는 여성들도 모바일 애플리케이션을 통해 경구 피임약을 구할 수 있게 되었으며, 진료부터 제품 배송까지의 지연 시간이 최소화되고 있습니다. 이러한 변화로 인해 피임약 사용이 증가하고 있으며, 온라인 약국과의 제휴 이후 이용률이 크게 상승했음을 보여주는 주목할 만한 연구 결과에서도 이를 뒷받침하고 있습니다. 이러한 수요 증가에 대응하여 각 제약사는 약국 판매에 적합한 제형을 제품 라인업에 추가하는 한편, 신흥 시장의 규제 당국 승인을 획득하는 데 주력하고 있습니다. 그 결과, 신규 진입 기업들이 동남아시아 등 지역에서 입지를 강화하고 있으며, 이러한 지역에서는 재정 지원 및 지역사회와의 협력 이니셔티브를 통해 매출 성장이 더욱 촉진될 것으로 예측됩니다.
세계 단기 작용 피임약 시장의 성장요인
세계 단기 작용 피임약 시장은 이러한 피임법의 장점, 특히 장기적인 피임법과 비교했을 때의 유연성과 신속한 중단 가능성에 대한 소비자의 인식이 높아짐에 힘입어 눈부신 성장을 이루고 있습니다. 일시적인 임신 방지를 원하는 사람들이 늘어남에 따라, 사용을 시작하거나 중단하기 쉬운 제품에 대한 관심이 높아지고 있습니다. 이에 대응하여 의료 종사자들은 변화하는 라이프스타일에 맞춘 편의성이 높은 피임 솔루션을 제안함으로써 환자의 요구에 적극적으로 부응하고 있으며, 그 결과 처방률과 일반의약품의 접근성 모두 향상되고 있습니다. 이처럼 충분한 정보에 기반한 소비자의 선택이 촉진됨에 따라, 전 세계 다양한 인구층에서 강력한 성장 동력이 생겨나며 시장 확대를 뒷받침하고 있습니다.
세계 단기 작용 피임약 시장의 제약요인
세계 단기 작용 피임약 시장은 이러한 제품에 포함된 호르몬 성분에 대해 규제 당국이 부과하는 엄격한 평가 절차로 인해 큰 제약에 직면해 있습니다. 해당 당국은 시장 진입을 허가하기 전에 종합적인 안전성 데이터를 요구하고 있으며, 이로 인해 승인까지의 기간이 장기화될 뿐만 아니라, 변화하는 기준을 준수하기 위해 제품 처방을 변경해야 할 수도 있습니다. 그 결과, 기업들은 제품 파이프라인의 지연을 겪는 경우가 많으며, 혁신 추구보다는 규제 준수에 자원을 할당해야 하는 상황에 처해 있습니다. 이러한 규제 부담의 증가는 신제품 출시를 방해할 뿐만 아니라 시장 성장을 억제하며, 투자자와 개발자 모두에게 막대한 불확실성을 초래하고 있습니다.
세계 단기 작용 피임약 시장의 동향
세계 단기 작용 피임약 시장은 디지털 채널의 통합을 원동력으로 큰 변화를 겪고 있습니다. E-Commerce 플랫폼과 원격의료 서비스의 부상은 피임약의 마케팅과 유통에 혁명을 일으키고 있으며, 각 브랜드가 소비자에게 더 직접적이고 효과적으로 접근할 수 있게 하고 있습니다. 타겟을 명확히 한 소셜 미디어 캠페인과 온라인 상담에 주력함으로써, 각 기업은 편의성과 사생활 보호에 대한 높아지는 수요에 부응하고, 소비자 직접 판매형 구독 모델을 통해 고객 충성도를 높이고 있습니다. 이러한 디지털화의 진전은 기존 약국 채널에 대한 의존도를 낮출 뿐만 아니라, 제조사가 분석 데이터를 활용하여 변화하는 소비자의 취향에 신속하게 적응할 수 있게 하여, 경쟁 구도에서 유리한 입지를 확보하는 데 기여하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 단기 작용 피임약 시장 규모 : 제품 유형별
세계의 단기 작용 피임약 시장 규모 : 호르몬 유형별
세계의 단기 작용 피임약 시장 규모 : 유통 채널별
세계의 단기 작용 피임약 시장 규모 : 최종사용자별
세계의 단기 작용 피임약 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.28Global Short Acting Contraceptives Market size was valued at USD 23.0 Million in 2024 and is poised to grow from USD 23.74 Million in 2025 to USD 30.54 Million by 2033, growing at a CAGR of 3.2% during the forecast period (2026-2033).
The global market for short-acting contraceptives is experiencing significant growth, driven by the rise of digital health platforms that simplify the prescription process and expand accessibility. Telemedicine allows women, particularly in remote areas, to access oral contraceptives via mobile applications, thereby minimizing delays between consultation and product delivery. This shift has led to increased contraceptive usage, as evidenced by notable studies indicating substantial uptake boosts following partnerships with e-pharmacies. In response to this heightened demand, manufacturers are broadening their product offerings to include pharmacy-friendly formulations and are focusing on securing regulatory approvals in emerging markets. Consequently, new market entrants are establishing their presence in regions like Southeast Asia, where financial support and community engagement initiatives are projected to further enhance sales growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Short Acting Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Short Acting Contraceptives Market Segments Analysis
Global short acting contraceptives market is segmented by product type, hormone type, distribution channel, end user and region. Based on product type, the market is segmented into Oral Contraceptive Pills, Injectable Contraceptives, Vaginal Rings, Transdermal Patches and Other Short-Acting Contraceptives. Based on hormone type, the market is segmented into Combined Hormonal Contraceptives and Progestin-Only Contraceptives. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Family Planning Clinics. Based on end user, the market is segmented into Hospitals, Clinics and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Short Acting Contraceptives Market
The Global Short Acting Contraceptives market is experiencing significant growth driven by a rise in consumer awareness regarding the advantages of these methods, particularly their flexibility and quick reversibility compared to long-term options. As individuals increasingly seek temporary pregnancy prevention, they gravitate towards products that offer the ability to initiate or discontinue use with ease. In response, healthcare providers are actively addressing patient needs by suggesting convenient contraceptive solutions that cater to evolving lifestyles, thereby boosting both prescription rates and over-the-counter availability. This empowerment of informed consumer choice is generating strong momentum across various demographic groups worldwide, enhancing the market's expansion.
Restraints in the Global Short Acting Contraceptives Market
The Global Short Acting Contraceptives market faces significant restraints due to the rigorous evaluation procedures imposed by regulatory agencies concerning the hormonal components in these products. These agencies demand comprehensive safety data prior to allowing market entry, which extends approval times and may necessitate alterations in product formulations to comply with changing standards. As a result, companies often encounter delays in their product pipelines and find themselves diverting resources to focus on compliance rather than pursuing innovation. This increased regulatory burden not only hampers the launch of new offerings but also restricts market growth and generates considerable uncertainty for both investors and developers.
Market Trends of the Global Short Acting Contraceptives Market
The Global Short Acting Contraceptives market is experiencing a significant transformation driven by the integration of digital channels. The emergence of e-commerce platforms and telehealth services is revolutionizing the marketing and distribution of contraceptives, enabling brands to reach consumers more directly and effectively. With a focus on targeted social media campaigns and virtual consultations, companies are catering to the growing demand for convenience and privacy, fostering consumer loyalty through direct-to-consumer subscription models. This digital evolution not only reduces reliance on traditional pharmacy channels but also allows manufacturers to leverage analytics for swift adaptation to changing consumer preferences, positioning them favorably in the competitive landscape.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Short Acting Contraceptives Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Oral Contraceptive Pills
- Injectable Contraceptives
- Vaginal Rings
- Transdermal Patches
- Other Short-Acting Contraceptives
Global Short Acting Contraceptives Market Size by Hormone Type & CAGR (2026-2033)
- Market Overview
- Combined Hormonal Contraceptives
- Progestin-Only Contraceptives
Global Short Acting Contraceptives Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Family Planning Clinics
Global Short Acting Contraceptives Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Clinics
- Homecare
Global Short Acting Contraceptives Market Size & CAGR (2026-2033)
- North America (Product Type, Hormone Type, Distribution Channel, End User)
- US
- Canada
- Europe (Product Type, Hormone Type, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Hormone Type, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Hormone Type, Distribution Channel, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Hormone Type, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Organon & Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lupin Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viatris Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amneal Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mayne Pharma Group Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Exeltis Healthcare S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratorios Leon Farma, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HRA Pharma SAS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gedeon Richter Plc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shanghai Dahua Pharmaceutical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Janssen Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Afaxys Pharma, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perrigo Company plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
